Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies

CARLSBAD, Calif. -- Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies focused on the generation of data that may improve clinical outcomes for patients in the future. As part of an initial pilot focused [...]

Tommi Kaasalainen appointed as new CEO of Euformatics

HELSINKI, Finland – Euformatics, a Finnish software company specialising in bioinformatics for genomic applications, has appointed Tommi Kaasalainen as its new CEO as of September 21st 2020. Olli Pasanen has stepped down from the position of CEO but will continue to play an integral role in the operation of the company as Chairman of the Board. Tommi brings with [...]

L7 Informatics to deploy ESP in QIAGEN’s Genomics Service Labs to improve laboratory workflows and data management.

Additional development projects planned to accelerate QIAGEN's Sample to Insight workflows through delivery of digital laboratory tools. L7 Informatics, provides software and services that enable synchronized solutions for scientific research and development. L7’s Enterprise Science Platform (ESP) is a scientific information management (SIM) solution that enables crop science companies to connect wet lab, greenhouses, sequencing [...]

Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor®

New AIDD Module applied to active therapeutic program to provide lead optimization support Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it entered into a collaborative research agreement with a large pharmaceutical company to evaluate the new AIDD Module in the [...]

ERS Genomics appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development

DUBLIN, Ireland: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will [...]

Eurisotop Responds to Market Demand for Deuterated Chloroform

Saclay, France Eurisotop, a wholly owned subsidiary of Cambridge Isotope Laboratories, Inc. (CIL), announced a capacity expansion of its deuterated chloroform production. Since its acquisition by CIL in 2001, Eurisotop has become a leading producer of deuterated NMR solvents and is the premier supplier of CIL stable isotope-labeled compounds in Europe. Eurisotop initially operated one reactor that produced 6 [...]

Waters Establishes Flagship Innovation and Research Laboratory in Cambridge, MA

Immerse Cambridge unveiled as an open, collaborative environment designed to accelerate cutting-edge scientific innovations CAMBRIDGE, Mass. -- Waters Corporation (NYSE:WAT) announced this week at Biotech Week Boston the establishment of Immerse™ Cambridge, a new Waters' research laboratory in the heart of Cambridge’s Kendall Square. Immerse Cambridge will serve as a strategic, collaborative space in the community, where Waters can partner with academia, [...]

Avantor® Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe

Expands responsibility to include Americas region Retains leadership of Europe and global Laboratory Products Group RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced Frederic Vanderhaegen has been appointed Executive Vice President, Americas and [...]

Genetics Research and Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform

Genetics Research, LLC ("GR"), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. ("Oxford Nanopore") based in Oxford, United Kingdom. This license enables Oxford Nanopore to use GR patents [...]

BIO-TECHNE ANNOUNCES COMMERCIAL RELEASE OF NEW CO-DETECTION ASSAYS FOR SIMULTANEOUS DETECTION OF RNA AND PROTEIN ON THE SAME SAMPLE

Expanding Bio-Techne's lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables visualization of single-molecule [...]

Access IBO on Knowledge Center